Trust Board of Directors Public. Denise Gale. For Assurance and Information NOT APPLICABLE NOT APPLICABLE NOT APPLICABLE NOT APPLICABLE
|
|
- Wesley Carson
- 5 years ago
- Views:
Transcription
1 NLG(18)014 DATE OF MEETING 30 January 2018 REPORT FOR Trust Board of Directors Public REPORT FROM Richard Sunley, Deputy Chief Executive CONTACT OFFICER Denise Gale SUBJECT Cancer Performance and Backlog Presentation BACKGROUND DOCUMENT (IF ANY) Previous Performance Reports Received by Trust Board PURPOSE OF THE PAPER: For Assurance and Information EXECUTIVE SUMMARY (PLEASE INCLUDE A BRIEF SUMMARY OF THE PAPER, KEY POINTS & ANY RISK ISSUES AND MITIGATING ACTIONS WHERE APPROPRIATE) This presentation includes : Last 12 months performance and forecast position for December, Q3 and January. Background and context as it relates to NLaG Comparisons re referrals and treatments within Humber, Coast & Vale Cancer Alliance Backlog position (>62 days) from November 17 to January 18 Confirmed cancer diagnoses >63 days, volumes with and without TCI dates (by tumour site) Suspected cancer pathways without diagnoses >63 days (by tumour site) 62 day draft trajectory to meet compliance by end June 18 (with caveats) 62 day improvement plan key themes/issues Other cancer work streams HAVE STAFF SIDE BEEN CONSULTED ON THE PROPOSALS? NOT APPLICABLE HAVE THE RELEVANT SERVICE USERS/CARERS BEEN CONSULTED ON THE PROPOSALS? NOT APPLICABLE ARE THERE ANY FINANCIAL CONSEQUENCES ARISING FROM THE RECOMMENDATIONS? NO IF YES, HAVE THESE BEEN AGREED WITH THE RELEVANT BUDGET HOLDER AND DIRECTOR OF FINANCE, AND HAVE ANY FUNDING ISSUES BEEN RESOLVED? NOT APPLICABLE ARE THERE ANY LEGAL IMPLICATIONS ARISING FROM THIS PAPER THAT THE BOARD NEED TO BE MADE AWARE OF? NOT APPLICABLE WHERE RELEVANT, HAS PROPER CONSIDERATION BEEN GIVEN TO THE NHS CONSTITUTION IN ANY DECISIONS OR ACTIONS PROPOSED? NOT APPLICABLE WHERE RELEVANT, HAS PROPER CONSIDERATION BEEN GIVEN TO SUSTAINABILITY IMPLICATIONS (QUALITY & NOT APPLICABLE
2 FINANCIAL) & CLIMATE CHANGE? THE PROPOPSALS OR ARRANGEMNTS OUTLINED IN THIS PAPER SUPPORT THE ACHIEVEMENT OF THE TRUST OBJECTIVE(S) For Information THE PROPOSAL OR ARRANGEMENTS OUTLINED IN THIS PAPER ENSRE COMPLIANCE WITH THE REGULATORY OR GOVERNANCE REQUIREMENTS LISTED THE PROPOSALS OR ARRAGEMENTS OUTLINED IN THIS PAPER TAKE ACCOUNT OF REQUIREMENTS IN RESPECT OF EQUALITY & DIVERSITY NOT APPLICABLE ACTION REQUIRED BY THE BOARD The Board is asked to note the contents of this report
3 Northern Lincolnshire & Goole NHS Foundation Trust Cancer Performance and Backlog >62 days Denise Gale 10 January 2018
4 This presentation includes : Last 12 months performance and forecast position for December, Q3 and January Background and context as it relates to NLaG Comparisons re referrals and treatments within Humber, Coast & Vale Cancer Alliance Backlog position (>62 days) from November 17 to January 18 Confirmed cancer diagnoses >63 days, volumes with and without TCI dates (by tumour site) Suspected cancer pathways without diagnoses >63 days (by tumour site) 62 day draft trajectory to meet compliance by end June 18 (with caveats) 62 day improvement plan key themes/issues Other cancer workstreams
5 Cancer Performance 1 The table below shows the current confirmed 62 day November performance (validated and uploaded to Open Exeter) and forecast Dec, Q3 and Jan performance (unvalidated). The deadline for upload to Open Exeter for December performance is 5 th Feb 2018 figures are always unvalidated/provisional until final upload has taken place 2ww 1 st seen (93%) forecast to breach in Jan. 40 breaches 50% (20) of are due to OPA capacity
6 Cancer Performance 2 The current weekly performance forecast is based on confirmed diagnosis patients with scheduled treatment dates in January as at 5 th January There are 36 patients with a confirmed cancer diagnosis >62 days, of which 24 do not have treatment dates; some are waiting treatment dates at NLaG whilst some are waiting treatment dates at tertiary providers. There are currently risks to delivery of the following cancer targets in January 2018: 2ww 1 st seen appointment 2ww Breast symptomatic 1 st seen appointment 62 day first definitive treatment
7 Background and Context 1 NLaG is a District General Hospital which delivers local cancer treatments. Specialist treatments, consistent with improving outcomes guidance (IOG), are delivered at specialist/tertiary centres, the main centre being HEY. NLaG has experienced a reduction in the volume of treatments over the past 12 months which has reduced the denominator against which performance is calculated In 2017, NLaG delivered an average 76.5 treatments per month (912.5 treatments over the period Jan 16 to Nov 17). This is considerably lower than the previous 12 months when NLaG delivered an average 86 treatments per month (1033 treatments over the period Jan 16 to Dec 16). Most tertiary centres deliver circa 120+ treatments per month. The Trust has also seen a rise in the volume of breaches of the 62 day standard over the past 12 months.
8 Background and Context 2 The local commissioning decision to redirect skin referrals to Virgin Care has reduced the volume of cancer treatments delivered at NLaG. The reduction in treatments has coincided with a rise in referrals, following publication of revised NICE referral guidance (2016) for primary care. This has reduced the conversion rate from referral for suspected cancer to treatment in most Trusts from circa 10-15% down to 6-8% which reduces the denominator further. The impact has been more severe at NLaG (as with other District General Hospitals) as it delivers a smaller proportion of treatments than tertiary centres.
9 HCV CA referrals comparisons 1 The graphs below (produced by HCV CA) show the significance of the reduction in total referrals, and specifically in skin cancer referrals compared to HEY and York. The reduction in skin cancer referrals follows a local commissioning decision to manage all dermatology through Virgin Care. The graph on the left shows the volume of all cancer treatments delivered at NLaG compared to HEY and York.
10 HCV CA referrals comparisons 1 Urology : volume of referrals for Urology are equal to or greater than HEY which demonstrates the pressure on this service at NLaG. Testicular : the number of referrals for testicular cancer are almost equal to that of HEY, and are greater than York.
11 Humber, Coast & Vale Comparisons 3 Upper GI : referrals are equal to or greater than York which demonstrates the pressure on this service. Most cancer surgical treatments are performed at HEY, with only a small proportion of treatments performed at NLaG. This means most treatments (and breaches) are shared (0.5 accountable treatments/breaches) with HEY, and NLaG does not get the benefit of full accountable treatment for these patients. Skin : Significant reduction in treatments Jan 16 to Dec 17 Jan - Dec 16 : Average treatments per month 7.5 Jan - Dec 17 : Average treatments per month 4.0 (with average 2.0 June - Dec 17).
12 62 day pathway : Backlog position 1 The volume of patients currently on the PTL without diagnosis has an adverse impact on the quality and efficiency of the tracking. Specialities with the greatest volume of patients >62 days in the backlog cohort are : Colorectal Head & Neck Skin (majority of treatments at NLaG are in the Head & Neck region). Upper GI
13 62 day pathway : Backlog position 2 The table below shows the cohort of patients with confirmed diagnosis of cancer (>62 days) by tumour site, and those that have confirmed treatment dates the month treatment is scheduled (with TCI date). With diagnosis - confirmed cancer with diagnosis days days days days with TCI (month) without TCI with diagnosis with TCI (month) without TCI with with TCI diagnosis (month) without TCI with with TCI diagnosis (month) without TCI with with TCI diagnosis (month) 104+ days Total without TCI with with TCI diagnosis (month) without TCI Trustwide total Breast 0 1 (Jan) (Jan) 1 Colorectal (Jan) (Jan) 3 Gynae Haematology Head & Neck (Jan) (Jan) 4 Lung (Jan) (Jan) 5 Other Skin (Jan) (Jan) 2 Upper GI Upper GI-OG Upper GI - HPB (Jan) (Jan) 1 Urology 2 1 (Jan) (Jan) (Jan) (Jan) 7
14 62 day pathway : Backlog position 3 The table below shows the cohort of patients without diagnosis >62 days this cohort of patients are continuing on the diagnostic pathways. It is also split by tumour site. Without diagnosis days suspected cancer days days days 104+ days Total Trustwide total Breast Colorectal Gynae Haematology Head & Neck Lung Other Skin Upper GI Upper GI-OG Upper GI - HPB Urology
15 62 day draft trajectory Scenario C : To achieve compliance with 62 day standard in June 18 (data upload) Trust Total Jan-18 Feb-18 Mar-18 Apr-18 May-18 Jun-18 Jul-18 Aug-18 Sep-18 Oct-18 Nov-18 Dec-18 Jan-19 Feb-19 Mar-19 No. of treatments No. of breaches % achievement 68.0% 69.9% 76.3% 79.7% 83.6% 86.7% 87.8% 87.2% 85.6% 85.9% 86.2% 86.5% 86.9% 86.2% 87.1% Assumes treatments are greater than rolling average, but continue to decrease throughout financial year. Assumes breaches are reduced to less than half that of current levels and rolling average The table and graph show the trajectory to achieve compliance of the 62 day standard by end June 18. This is caveated by the following : a) Volume of treatments are consistent with forecast b) Volumes of breaches are reduced to the levels indicated c) The existing backlog (cancer and undiagnosed patients) is cleared by end February 18 d) There is a reduction in late (> day 38) referrals to tertiary providers reallocation impact has not been built into this trajectory.
16 62 day improvement plan: Key Themes 1 Tumour site / issue Actions 62 day improvement trajectory The Trust is developing an improvement trajectory at trustwide and tumour site level to reduce the volume of breaches from current levels (24.0 per month) to 10 accountable breaches per month. This will be particularly difficult, once the national inter-provider transfer standard (Day 38) is implemented in April 2018 but is necessary to deliver the 62 day standard. Reduction in 104+ backlog (confirmed cancer and suspected cancer) Reduction in 63+ days backlog (confirmed cancer and suspected cancer) The Trust aims to a) ensure that all confirmed cancer patients, where the treatment is undertaken at NLaG, will have confirmed treatment dates by the end of January. b) that all suspected cancer patients, where the diagnostic pathway is undertaken at NLaG, will have a definitive diagnosis by end January 18, c) Ensure all confirmed cancers have a TCI date (where treatment is undertaken at NLaG) by end February. d) Work with tertiary providers to ensure these patients have a treatment date as quickly as possible (confirmed cancer) and reach definitive diagnosis (undiagnosed).
17 62 day improvement plan: Key Themes 2 Tumour site / issue Incorrect priority on test request/histology samples OPA and surgical capacity Colorectal Straight to Test pathway Delays in clinical decision making Risk stratified follow up pathways MDT discussions Histology reporting capacity Diagnostic capacity Actions Divisions are working with clinical teams to ensure that the 2ww priority is clearly marked and visible on all samples where the patient is on a cancer pathway. Plans are being developed internally to address capacity shortfalls. The Royal Marsden Partners Vanguard work on the STT colorectal pathway has been shared internally and is being considered. As a result of shortfall in clinical manpower, a number of specialities have seen delays in reviewing notes for removal from pathways, which has impacted on the backlog (undiagnosed) position. To be developed to support capacity improvements Multiple MDT discussions/differential practice between SGH and DPoW; particularly when test results are non-diagnostic. Path Lincs is continuing to recruit locums (short-term) and substantive staff. Plans are being developed internally to reduce reporting turnaround time for 2ww priority to 7 days. There remain challenges with capacity at SGH for Colonoscopy, CT Colonography and Upper GI Endoscopy.
18 62 day improvement plan: Key Themes 3 Tumour site / issue Diagnostic- repeat tests Cancer Weekly PTL Cancer reporting CWT data validation CWT training Clinical Harm Reviews >104 days Clinical Harm Reviews Backlog (April to December) Actions There are a number of specialties where repeat tests occur when the result is non-diagnostic. Review of PTL processes, actions and escalations. Working with NHSI (IST) team to improve effectiveness of PTL. Work is ongoing to ensure that the information team support the cancer team with weekly, monthly reporting and dashboard development to give the Executive Team greater transparency. Discussions are ongoing within the Trust to develop a central team who will support cancer waiting times (and SACT - Systemic Anti Cancer Therapy) data validation and submission. Development of a training programme in awareness of CWT rules aimed at administrative teams who record CWT data, MDT clinical leads, Cancer Nurse Specialists. This is part of a programme of work with NHS Improvement. RCA timelines are being produced by the cancer team, sent to clinicians/ business groups to agree reasons for breach. They are saved into a folder within one month of treatment taking place, and are ready for upload to the COBRA system, which will instigate the harm review with clinical teams. Harm reviews will then be tracked through COBRA and outcomes used to improve cancer pathways. The backlog of patients April-December are ready for dissemination to clinical teams/business groups. That is to say the RCAs are completed and ready for upload to COBRA.
19 Other Cancer Workstreams Workstream Management of CSC team Haematology/chemotherapy QST (formerly peer review) SACT (Systemic Anti Cancer Therapy) data Cancer Board Review of CSC workforce Planned Care Board Actions It is intended to centralise the management of the Cancer Co-ordinator team under the Cancer Management Team to give greater support to these staff members. A consultation paper will be drafted by end Jan 18. The hospital received a visit from the national QST team in December. A number of immediate risks and serious concerns were raised and the Trust is developing an action plan to address these issues. This will be led by the Corporate QST lead with support from the Cancer Team. A workstream to look at extracting SACT data direct from the e-prescribing system (Varian) has commenced, in conjunction with HEY. This will enable the Trust to become compliant with national requirements. Deadline for achieving this has been set at 31 st March The Trust is in the process of establishing an internal Cancer Board comprising clinicians, nurses, managers and supported by the Cancer Management Team. This will have a strategic overview of cancer, will be accountable to the Trust Board through its governance structures, and will provide advice and recommendations to the Trust Board on all cancer issues. It is anticipated to hold the first meeting in February. A review of the CSC workforce is planned during January using NHS Improvement team tools to compare the current workforce (hours) with the time required for each tumour site. Development of cancer work programme is in progress which will be monitored at the internal planned care board.
Brighton and Sussex University Hospitals NHS Trust Board of Directors. Mark Smith Chief Operating Officer
Meeting: Brighton and Sussex University Hospitals NHS Trust Board of Directors Date: 24 th August 2015 Board Sponsor: Paper Author: Subject: Mark Smith Chief Operating Officer Clinical Director and Directorate
More informationIntegrated Cancer Services Action Plan. Colchester Hospital University NHS Foundation Trust 31 March 2014
Integrated Cancer Services Action Plan Colchester Hospital University NHS Foundation Trust 31 March KEY Implemented, clearly evidenced and externally approved On Track to deliver Some issues narrative
More informationAPPENDIX ONE. 1 st Appointment (Non-admitted) recovery trajectories
APPENDIX ONE 1 st Appointment (Non-admitted) recovery trajectories The following trajectories show reductions in total waiting list sizes for first appointments. It is difficult for any organisation to
More informationRTT Exception Report
Appendix 3 RTT Exception Report 1. Purpose To provide a summary of factors impacting on 18 week RTT performance and a revised forecast of red rated performance for Quarter 2 2015/16 for the admitted pathway.
More informationCancer Improvement Plan Update. September 2014
Cancer Improvement Plan Update September 2014 1 Contents Page 1. Introduction 3 2. Key Achievements 4-5 3. Update on Independent Review Recommendations 6-13 4. Update on IST Recommendations 14-15 5. Update
More informationCancer Services Position & Recovery Plan June 2015
Appendix 6 Cancer Services Position & Recovery Plan June 2015 Introduction The Trust is required to achieve 85% compliance for patients on a 62 day pathway from the referral date to the date they receive
More information18 WEEK RTT RECOVERY PLAN. April 2015
18 WEEK RTT RECOVERY PLAN April 2015 1. Background WHHT is not currently compliant with the national RTT standards which require 95% of non-admitted and 90% of admitted patients to receive their elective
More informationImproving Cancer Pathways. Mel Warwick Macmillan Cancer Manager / Lead Nurse Aintree University Hospital NHS Foundation Trust
Improving Cancer Pathways Mel Warwick Macmillan Cancer Manager / Lead Nurse Aintree University Hospital NHS Foundation Trust Background Poor / inconsistent 62 day performance, across a number of specialities
More informationNational Cancer Peer Review Programme
National Cancer Peer Review Programme Julia Hill Acting Deputy National Co-ordinator What is Cancer Peer Review? A quality assurance process for cancer services. An integral part of Improving Outcomes
More informationSouth West Cancer Alliances Rapid Diagnostic Pathway for Lung Cancer Project Evaluation
Somerset, Wiltshire, Avon and Gloucestershire Cancer Alliance Peninsula Cancer Alliance South West Cancer Alliances Rapid Diagnostic Pathway for Lung Cancer Project Evaluation Peninsula Thoracic-Oncology
More informationIntegrated Cancer Services Action Plan. Colchester Hospital University NHS Foundation Trust 30 th June 2014
Integrated Cancer Services Action Plan Colchester Hospital University NHS Foundation Trust 30 th June KEY Implemented, clearly evidenced and externally approved On Track to deliver Some issues narrative
More informationTrust Board Meeting in Public: Wednesday 11 July 2018 TB
Trust Board Meeting in Public: Wednesday 11 July 2018 Title Integrated Performance Report: Month 2 Status History For information. The report provides a summary of the Trust s performance against a range
More information18 Week 92% Open Pathway Recovery Plan and Backlog Clearance
18 Week 92% Open Pathway Recovery Plan and Backlog Clearance Page 1 of 6 17.05.2012 1.0 Background 18-Week 92% Open Pathway RECOVERY PLAN The Trust has achieved compliance against the admitted and non-admitted
More informationThe Single Cancer Pathway
The Single Cancer Pathway Background and Case for Change Case for Change (1) Broadly patient experience of cancer services in Wales is good: 93% of patients rate their care as 7/10 or better (WPES) But
More informationSpecial Measures Action Plan. Colchester Hospital University NHS Foundation Trust Cancer Action Plan 30 th November 2014
Special Measures Action Plan Colchester Hospital University NHS Foundation Trust Cancer Action Plan 30 th November KEY Delivered On Track to deliver Some issues narrative disclosure Not on track to deliver
More informationBriefing Paper. Single Cancer Pathway
Briefing Paper Single Cancer Pathway Author: Tom Crosby, Clinical Director, Wales Cancer Network Owner: Wales Cancer Network Date: 27 th November 2017 Version: 1.0 Publication/ Distribution: Wales Cancer
More informationUnless this copy has been taken directly from the Trust intranet site (Pandora) there is no assurance that this is the most up to date version
Policy No: OP90 Version: 1.0 Name of Policy: Cancer Services Operational Policy Effective From: 02/11/2016 Date Ratified 30/11/2015 Ratified Corporate Management Team Review Date 01/11/2017 Sponsor Director
More informationTransforming Cancer Services for London
Programme Director Paul Roche Status Draft Owner Laura Boyd Version 0.4 Author Jennifer Layburn Date 15/05/13 Transforming Cancer Services for London Best Practice Commissioning Pathway for the early detection
More informationCancer Transformation Programme
Cancer Transformation Programme Introduction to and supporting documentation for VALUE BASED TRANSFORMATION FUNDING SITE SELECTION November 2016 1 Introduction and Contents The Planning Guidance for 2017-2019
More informationSouth Norfolk CCG Dementia Strategy and Action Plan Dr Tony Palframan, SNCCG Governing Body Member
Agenda item: 9.4 Subject: Presented by: Submitted to: South Norfolk CCG Dementia Strategy and Action Plan Dr Tony Palframan, SNCCG Governing Body Member Governing Body Date: 28 th July Purpose of paper:
More informationTrust Board meeting in Public: Wednesday 14 November 2018 TB
Trust Board meeting in Public: Wednesday 14 November 20 Title Integrated Performance Report: Month 6 Status History For information. The report provides a summary of the Trust s performance against a range
More informationCancer Access Policy. Key Points
Trust Policy Cancer Access Policy Key Points The timescales within which cancer patients are treated is a vital quality measure and key indicator of the quality of cancer services offered at the Trust.
More informationFaster Cancer Treatment: Using a health target as the platform for delivering sustainable system changes
Faster Cancer Treatment: Using a health target as the platform for delivering sustainable system changes Organisation Name: Ko Awatea, Counties Manukau Health Presenter: Bob Diepeveen HRT 1520 Innovations
More informationCIG SCP Health Board/Velindre Implementation Plan (Aneurin Bevan University Health Board)
CIG SCP Health Board/Velindre Implementation Plan (Aneurin Bevan University Health Board) 1 Governance, Leadership and Planning a) Describe your SCP Programme Board (or equivalent), its membership and
More informationLung cancer timed clinical pathways
Lung cancer timed clinical pathways December 2017 1 Context This document sets out best practice timed clinical pathways for lung cancer. It is anticipated that all Cancer Alliances will audit against
More informationThere are a number of national guidelines and performance standards which support the implementation of a straight to CT pathway.
December 2015 CONTENTS Contents... 2 1 Introduction... 3 2 Case for Change... 3 3 Evidence... 3 3.1 National and regional policy... 3 3.2 Local audit... 4 4 Supporting Work Initiatives... 5 4.1 Identification
More informationNORTHERN HEALTH AND SOCIAL CARE TRUST. Waiting Times Summary Report
NORTHERN HEALTH AND SOCIAL CARE TRUST Waiting Times Summary Report April 2014 1 Waiting Times The Northern Health & Social Care Trust monitors waiting time performance against a number of Departmental
More informationWELCOME AND INTRODUCTIONS. Sarah Tedford Chief Operating Officer Barking, Havering and Redbridge University Hospitals NHS Trust (BHRUT)
WELCOME AND INTRODUCTIONS Sarah Tedford Chief Operating Officer Barking, Havering and Redbridge University Hospitals NHS Trust (BHRUT) ABOUT US OUR COMMUNITY Two main hospital sites King George Hospital
More informationNational Optimal Lung Cancer Pathways. Dr Sadia Anwar Nottingham University Hospitals NHS Trust Clinical Lead for Lung Cancer
National Optimal Lung Cancer Pathways Dr Sadia Anwar ttingham University Hospitals NHS Trust Clinical Lead for Lung Cancer Overview How NOLCP evolved How it relates to national guidance Pathways Implementation
More informationUpper GI Cancer Network Site-Specific Group. Work Programme/Service Delivery Plan 2011/14
Upper GI Cancer Network Site-Specific Group Work Programme/Service Delivery Plan 2011/14 1 UPPER GI NSSG Work Programme/Service Delivery Plan AGREEMENT COVER SHEET 2011/14 This Work Programme has been
More informationNational Cancer Programme. Work Plan 2015/16
National Cancer Programme Work Plan 2015/16 Citation: Ministry of Health. 2015. National Cancer Programme: Work plan 2015/16. Wellington: Ministry of Health. Published in October 2015 by the Ministry of
More informationGOVERNING BODY MEETING in Public 22 February 2017 Agenda Item 3.4
GOVERNING BODY MEETING in Public 22 February 2017 Paper Title Purpose of paper Redesign of Services for Frail Older People in Eastern Cheshire To seek approval from Governing Body for the redesign of services
More informationDorset Cancer Alliance:
Dorset Cancer Alliance: - Structure and Functions - SSG specification Where are we without a Network? Wessex Strategic Cancer Network Individual Trust Cancer Services Dorset CCG Specialised Commissioning
More informationCancer Outcomes and Services Dataset: Implications for clinical teams
Cancer Outcomes and Services Dataset: Implications for clinical teams Mick Peake Clinical Lead, NCIN National Clinical Lead, NHS Cancer Improvement Consultant & Senior Lecturer in Respiratory Medicine,
More informationCancer Alliance Data Pack
Humber, Coast and Vale Cancer Alliance Data Pack By February 18 Version 1.2 Produced by the Cancer Alliance Data, Evidence and Analysis Service (CADEAS) For any enquiries contact: england.cadeas@nhs.net
More informationEnc 9 Appendix 5 RTT Recovery Plan June 2015 PROGRESS UPDATE MANAGE R LEAD RISKS TO DELIVERY OF ACTION COMPLETION ON DATE NUMBER ACTION EXEC LEAD
Enc 9 Appendix 5 RTT Recovery Plan June 2015 Status Key 5 Complete 4 On track 3 Some delay-expect to complete as planned or implemented but not consistently delivering 2 Significant delay unlikely to be
More informationReport. Page 113 of 220. NHS South Cheshire CCG and NHS Vale Royal CCG Joint Governing Body. Report To (committee):
Report Report To (committee): Report Title: Agenda No.: South Cheshire CCG and Vale Royal CCG Joint Governing Body Performance Report Meeting Date: Thursday 5 th April 2018 Report Author(s) Name/s Andy
More informationProgress Review of Five Cancer Services at Colchester Hospital University NHS Foundation Trust
Progress Review of Five Cancer Services at Colchester Hospital University NHS Foundation Trust 1 2 Progress Review of Five Cancer Services at Colchester Hospital University NHS Foundation Trust NHS England
More informationAlliance Diagnostic Hub for NEL. Cancer Collaborative Annual Review event
Alliance Diagnostic Hub for NEL Cancer Collaborative Annual Review event 26 th June 2018 There are clear national priorities for provision of Cancer Services National Context The Five Year Forward View,
More informationPresent: Name: Initials
Meeting: Cancer Unit Managers Date: 7 th November 2017 Time: 2.00 4.00pm Venue: Evolve Business Centre Present: Name: Initials Apologies: Linda Wintersgill, Information Manager, Cancer Alliance Soraya
More informationContract Headlines. OPD headlines 07Jan15
Contract Headlines OPD headlines 07Jan15 Contract Headlines Key issues: ENHT PAH Royal Free HUC Acute In Hours Visiting Service (AIHVS) Contract Headlines Updates: Format / frequency for future updates
More informationCancer Outcomes and Services Dataset. What is COSD? Skin Cancers Workshop October 2012
Cancer Outcomes and Services Dataset What is COSD? Skin Cancers Workshop October 2012 17 years ago......cancer registration and careful monitoring of treatment and outcomes are essential... Calman-Hine
More informationRichard Watson, Chief Transformation Officer. Dr P Holloway, GP Clinical Lead for Cancer Lisa Parrish, Senior Transformation Lead
GOVERNING BODY Agenda Item No. 08 Reference No. IESCCG 18-02 Date. 23 January 2018 Title Lead Chief Officer Author(s) Purpose Cancer Services Update Richard Watson, Chief Transformation Officer Dr P Holloway,
More informationDelivering 62 Day GP Cancer Waits in a Complex Landscape. Hannah Marder Cancer Manager University Hospitals Bristol
Delivering 62 Day GP Cancer Waits in a Complex Landscape Hannah Marder Cancer Manager University Hospitals Bristol Overview The 62 day GP target Cancer pathways What causes breaches? Good practice and
More informationFrom the Permanent Secretary and HSC Chief Executive
From the Permanent Secretary and HSC Chief Executive Dr Andrew Murrison MP Chair, N. Ireland Affairs Committee Committee Office House of Commons LONDON SW1A 0AA northircom@parliament.uk Castle Buildings
More informationDorset Health and Wellbeing Board
Dorset Health and Wellbeing Board Date of Meeting 09 November 2016 Subject of Report Sustainability and Transformation Plan Refresh Update Report Author Partner Organisation Tim Goodson, Chief Officer,
More informationNational Cancer Programme. Work Plan 2014/15
National Cancer Programme Work Plan 2014/15 Citation: Ministry of Health. 2014. National Cancer Programme: Work Plan 2014/15. Wellington: Ministry of Health. Published in December 2014 by the Ministry
More informationAneurin Bevan Health Board Access 2009 Performance Report
Access 2009 Performance Report 1. Introduction This paper outlines current progress in meeting the Access 2009 Referral to Treatment Time 26 week target. It highlights actions taken to date, key challenges
More informationANNUAL CANCER DELIVERY ACTION PLAN REPORT
AGENDA ITEM 6.4 6 May 2014 ANNUAL CANCER DELIVERY ACTION PLAN REPORT Executive Lead: Medical Director Author: UHB Cancer Lead Clinician/Cancer Lead Manager Contact Details for further information: Maggie
More informationNational Cancer Peer Review Sarcoma. Julia Hill Acting Deputy National Co-ordinator
National Cancer Peer Review Sarcoma Julia Hill Acting Deputy National Co-ordinator Improving Outcomes Guidance The Intentions of Improving Outcomes for People with Sarcoma Changes in the provision of care
More informationEffective Evidence Based Pathway Design
10 Sustaining Cancer Waiting Times through Effective Pathway Management. Effective Evidence Based Pathway Design Prospective Patient Management and Navigation Robust Data Information and Administrative
More informationAyrshire and Arran NHS Board
Paper 08 Ayrshire and Arran NHS Board Monday 25 November 2013 Waiting Times Report Author: Fraser Doris, Planning and Performance Officer Sponsoring Director: Liz Moore, Director of Acute Services Date:
More informationCABINET PROCURING A SUBSTANCE MISUSE & COMMUNITY TREATMENT SERVICE IN RUTLAND
CABINET Report No: 105/2017 PUBLIC REPORT 16 May 2017 PROCURING A SUBSTANCE MISUSE & COMMUNITY TREATMENT SERVICE IN RUTLAND Report of the Director of Public Health Strategic Aim: Safeguarding Key Decision:
More informationLeeds: Early Diagnosis Project updates
Leeds: Early Diagnosis Project updates Cancer Cascade Event, 11 th May 2017 Joanna Bayton-Smith, Macmillan Leeds Cancer Strategy, Programme Manager Objectives: To provide overview of Leeds Cancer Strategy
More informationSingle Suspected Cancer Pathway Definitions pathway start date
Single Suspected Cancer Pathway Definitions pathway start date Date: March 2018 Version: 1.2.1 Wales Cancer Owner: Network and Welsh Government Status Published 1 P a g e Purpose of Document This document
More informationInformatics in the new NHS : PHE and NCIN 9 months on. Nicky Coombes National Cancer Intelligence Network
Informatics in the new NHS : PHE and NCIN 9 months on. Nicky Coombes National Cancer Intelligence Network What was then... Key Funding Accountability Regulation Advice Parliament NICE Department of Health
More informationInsulin Administration Errors in Adult Community Nursing. Hedy Lehman Assistant Director of Professional Standards, Adult Community Nursing
Insulin Administration Errors in Adult Community Nursing Hedy Lehman Assistant Director of Professional Standards, Adult Community Nursing Organisational Background, Changes and Context Prior to April
More informationRuth Howkins Deputy National Coordinator National Cancer Peer Review
Ruth Howkins Deputy National Coordinator National Cancer Peer Review Purpose of Peer Review To ensure services are as safe as possible To improve the quality and effectiveness of care To improve the patient
More informationFFT and Patient Insight for Improvement. Marie Allen Head of Service User and Carer Experience
FFT and Patient Insight for Improvement Marie Allen Head of Service User and Carer Experience 142 Community Integrated Health and Adult Social Care Teams: District nurses Allied Health Professionals Dental
More informationCore Standard 24. Cass Sandmann Emergency Planning Officer. Pat Fields Executive Director for Pandemic Flu Planning
Trust Board Meeting Agenda Item 7 Date: 30 September 2009 Title of Report Recommendations (please outline the purpose of the report and the key issues for consideration/decision) Progress with Pandemic
More informationSupra Network Sarcoma Advisory Group (SAG) Annual Report
London and South East Sarcoma Network Supra Network Sarcoma Advisory Group (SAG) Annual Report 2011-2012 Hosted by Date: December 2012 Version: 2 Review Date: September 2013 London Cancer Integrated Cancer
More information62-day Cancer Performance and Action Plan. Dr Christian Hamilton, Divisional Manager CWH & Cancer Services
Agenda item: 9.2, Public Date: 31 July 2013 Title: 62-day Cancer Performance and Action Plan Prepared by: Dr Christian Hamilton, Divisional Manager CWH & Cancer Services Presented by: Em Wilkinson-Brice,
More informationRM Partners Accountable Cancer Network
The Royal Marsden RM Partners Accountable Cancer Network Dr. Shelley Dolan, Chief Nurse The Royal Marsden Executive Director Cancer Vanguard 1 Overview of the Cancer Vanguard Dr Shelley Dolan Executive
More informationCANCER OPERATIONAL POLICY
CANCER OPERATIONAL POLICY Document Author Written By: Lead Cancer Nurse/Peer Review and Administration Manager Date: October 2016 Authorised Authorised By: Chief Executive Date: 8 th vember 2016 Lead Director:
More informationDEMAND AND CAPACITY MODELLING
DEMAND AND CAPACITY MODELLING How we used demand and capacity modelling to develop a robust and credible recovery plan Piers Young Deputy Chief Operating Officer (Elective Care) CONTENTS Brief history
More informationUsing Cancer Registration and MDT Data to Provide Information on Recurrent and Metastatic Breast Cancer
Using Cancer Registration and MDT Data to Provide Information on Recurrent and Metastatic Breast Cancer Dr Gill Lawrence, WM KIT, on behalf of Breast SSCRG Cancer Outcomes Conference, Brighton, June 2013
More informationINTERNAL VALIDATION REPORT (MULTI-DISCIPLINARY TEAM)
INTERNAL VALIDATION REPORT (MULTI-DISCIPLINARY TEAM) Network Trust MDT NECN N Tees & Hartlepool North Tees And Hartlepool Date Self Assessment Completed 23rd July 2009 Date of IV Review 19th June 2009
More informationOne Palliative Care Annual Report
One 203 Palliative Care Annual Report One In 202, ASCO released a provisional clinical opinion stating that concurrent palliative care should be considered early in the course of advanced or metastatic
More informationAcute Oncology & Chemotherapy Clinical Network Group (CNG)
Acute Oncology & Chemotherapy Clinical Network Group (CNG) Work Programme 2014-2015 Version 1.0 This Work Programme has been agreed by: Title Name Date Agreed AO & Chemotherapy CNG Chair Ernie Marshall
More informationCathy Geddes: Chief Executive Officer Matt Riddleston: Trust Lead Macmillan Cancer Nurse Simon Smith: Trust Cancer Lead Clinician
Cancer Access and Operational Policy Policy Register No: 09124 Status: Public Developed in response to: CWT Version 9 Going Further on Cancer Waits Achieving World Class Cancer Outcomes A strategy for
More informationWork Programme/Service Delivery Plan 2010/2013
Essex and East Suffolk Gynaecological Cancer Network Site Specific Group Work Programme/Service Delivery Plan 2010/2013 Version Number 1.2 Author Members of the NSSG Date Written June 2010 Reviewed May
More informationTransforming Cancer Services Team
Transforming Cancer Services Team Healthy London Partnership Annual Report 2016/17 July 2017 Supported by and delivering for London s NHS, Public Health England and the Mayor of London Contents Who we
More informationThe NHS Cancer Plan: A Progress Report
DEPARTMENT OF HEALTH The NHS Cancer Plan: A Progress Report LONDON: The Stationery Office 9.25 Ordered by the House of Commons to be printed on 7 March 2005 REPORT BY THE COMPTROLLER AND AUDITOR GENERAL
More informationSERVICE TRANSITION PLAN SUMMARY. 1 Jan 2015 IHSS Service Transition Plans (version 8) 1
SERVICE TRANSITION PLAN SUMMARY 1 IHSS Service Transition Plans (version 8) 1 Summary Service Transition Plan Headlines XXX Target milestone date unknown pendency link Activity period Oct Nov c Jan Feb
More informationActivity Report July 2014 June 2015
Urological Cancers Managed Clinical Network Activity Report July 2014 June 2015 Mr Gren Oades Consultant Urologist MCN Clinical Lead Tom Kane MCN Manager CONTENTS EXECUTIVE SUMMARY 3 1. INTRODUCTION 5
More informationGREATER MANCHESTER EXPERIENCE
Greater Manchester Cancer Vanguard Innovation Remote Monitoring / Stratified Pathways GREATER MANCHESTER EXPERIENCE NADEEM AHMED - INFORMATICS ENTERPRISE ARCHITECT, DIGITAL PROJECTS @ The Christie Previously
More informationPeople living well with Dementia in the East Midlands: Improving the Quality of Care in Acute Hospitals
PROJECT INITIATION DOCUMENT We re in it together People living well with Dementia in the East Midlands: Improving the Quality of Care in Acute Hospitals Version: 1.1 Date: February 2011 Authors: Jillian
More informationReferral to treatment consultant-led waiting times
Referral to treatment consultant-led waiting times How to Measure DH INFORMATION READER BOX Policy Clinical Estates HR / Workforce Commissioner Development IM & T Management Provider Development Finance
More informationCommissioning Living with and Beyond Cancer in Yorkshire and Humber; an Overview.
Commissioning Living with and Beyond Cancer in Yorkshire and Humber; an Overview. Document Title An Overview of Commissioning Living with and Beyond Cancer in Yorkshire and Humber Version number: 1 First
More informationIAPT Performance Workshop
IAPT Performance Workshop May 2015 Els Drewek Head of Intensive Support) England (els.drewek @nhs.net) 1 This set of slides is provided in support of the interactive workshop on IAPT Performance and will
More informationCOSD & Source of Referral
COSD & Source of Referral A Brief guide October 2014 Michael Sharpe Data Improvement Manager National Cancer Registration Service What is COSD? Cancer and Outcomes Services Dataset Clinical dataset for
More informationHaemato-oncology Clinical Forum. 20 th June 2013
Haemato-oncology Clinical Forum 20 th June 2013 Welcome Dr Majid Kazmi, LCA Haemato-oncology Pathway Group Chair Purpose of today Provide an update on progress of the LCA to date Identify priorities for
More informationMonitoring Protocol for Clozapine-induced Myocarditis. Copyright 2017, CAMH
1 Monitoring Protocol for Clozapine-induced Myocarditis 1 Agenda Problem Identification / Identification Importance / Importance Baseline Workflow Baseline Workflow Baseline Data Baseline Data Objectives
More informationInstitute of Quality Leadership AMGA
Institute of Quality Leadership AMGA Ajay Sahajpal, MD Director Abdominal Transplant and Hepatobiliary Program Bradley Kruger, VP Operations ASLMC Laura Spurr, Director Clinical Transformation and Operations
More informationPrimary Health Networks
Primary Health Networks Drug and Alcohol Treatment Activity Work Plan 2016-17 to 2018-19 Drug and Alcohol Treatment Budget Murray PHN When submitting this Activity Work Plan 2016-2018 to the Department
More informationData briefing: Reflex testing for Lynch syndrome in people diagnosed with bowel cancer under the age of 50
Data briefing: Reflex testing for Lynch syndrome in people diagnosed with bowel cancer under the age of 50 Introduction Lynch syndrome is an inherited condition that predisposes individuals to bowel and
More informationPOLICY FOR CLINICAL AUDIT OF NEW CASES OF INVASIVE CERVICAL CANCER AND DISCLOSURE OF RESULTS
POLICY FOR CLINICAL AUDIT OF NEW CASES OF INVASIVE CERVICAL CANCER AND DISCLOSURE OF RESULTS Reference Number Version: Status Author: Alison Cropper CL-CP/2009/010 V3 Final Job Title: Hospital Based Programme
More informationLCA Lung Clinical Forum. 21 st October 2014
LCA Lung Clinical Forum 21 st October 2014 Welcome Dr Liz Sawicka Chair - LCA Lung Pathway Group Succession planning Dr Kate Haire Consultant in Public Health Medicine, LCA Commissioning Intentions for
More informationParity: Innovation in Practice
Parity: Innovation in Practice Karen Turner Director of Mental Health 11 February 2016 Why does parity matter? 1:4 adults experience at least one diagnosable mental health problem a year 1:10 children
More informationBreast Test Wales Screening Division Public Health Wales
Breast Test Wales Screening Division Public Health Wales Programme Level Agreement with Welsh Government Quarterly Report October - December Breast Test Wales - Quarterly Report October - December Service
More informationProject Initiation Document:
Project Initiation Document: Lancashire Support Services for Children, Young People, Families and Carers Affected by Autistic Spectrum Disorder (ASD) and Diagnosis 1. Background The Children and Young
More informationNORTHERN HEALTH AND SOCIAL CARE TRUST
NORTHERN HEALTH AND SOCIAL CARE TRUST Trust Corporate Performance Report June 2013 Date Issued: 24/07/13 Contents 1.0 Introduction / Summary 2.0 Commissioner Targets and Associated Activity 3.0 Access
More informationSouth Yorkshire, Bassetlaw and North Derbyshire Cancer Alliance Board
South Yorkshire, Bassetlaw and North Derbyshire Cancer Alliance Board Title Living with and Beyond Cancer programme - update for boards August 2017 Sponsor Lesley Smith, Chair of the South Yorkshire, Bassetlaw
More informationOFFICIAL. Document Status. NHS England INFORMATION READER BOX
NHS England INFORMATION READER BOX Directorate Medical Operations and Information Specialised Commissioning Nursing Trans. & Corp. Ops. Strategy & Innovation Finance Publications Gateway Reference: 07923
More informationJupiter Ward Dementia Friendly Environment report Introduction: Background. Evidence for change 1, 2, 3, 4, 6 :
Jupiter Ward Dementia Friendly Environment report Introduction: Jupiter ward is a 3 bedded Older Persons Care (OPC) ward which re-opened in November 214 following a total refurbishment. The project involved
More informationGOVERNING BODY REPORT
GOVERNING BODY REPORT DATE OF MEETING: 20th September 2012 TITLE OF REPORT: KEY MESSAGES: NHS West Cheshire Clinical Commissioning Group has identified heart disease as one of its six strategic clinical
More informationTRUST BOARD SUBMISSION TEMPLATE MEETING Trust Board - Public Ref No. 6.1
TRUST BOARD SUBMISSION TEMPLATE MEETING Trust Board - Public Ref No. 6.1 DIRECTOR Interim Director of Planning, Performance and Informatics Date 4 th October 2018 Trust Performance Report Purpose Corporate
More informationAHP Musculoskeletal Service Redesign. Judith Reid MSc MMACP Consultant Physiotherapist in MSK NHS Ayrshire and Arran
AHP Musculoskeletal Service Redesign Judith Reid MSc MMACP Consultant Physiotherapist in MSK NHS Ayrshire and Arran Local Drivers Routine referral practice Via acute care, duplication Long waiting times
More informationNewcastle Safeguarding Children Board Business Group Terms of Reference
Newcastle Safeguarding Children Board Business Group Terms of Reference 1. Purpose Newcastle Safeguarding Children Board (NSCB) Business Group will act as the executive business group on behalf of Newcastle
More informationSupporting and Caring in Dementia
Supporting and Caring in Dementia Surrey and Sussex Healthcare, Delivering the National Dementia Strategy Strategy and Implementation Plan Final November 2011 1 National Strategy The National Dementia
More information